Caxton Corporation’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,009
Closed -$158K 41
2021
Q4
$158K Hold
16,009
0.13% 46
2021
Q3
$158K Hold
16,009
0.13% 49
2021
Q2
$165K Hold
16,009
0.11% 51
2021
Q1
$163K Hold
16,009
0.11% 57
2020
Q4
$182K Buy
+16,009
New +$182K 0.11% 42